C4 Therapeutics (CCCC) Non Operating Income (2019 - 2026)
C4 Therapeutics (CCCC) posted Non Operating Income of $2.79 million for Q2 2026, up 12.4% from $2.48 million a year earlier and up 5.0% from the prior quarter.
C4 Therapeutics (CCCC) Non Operating Income (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Non Operating Income at C4 Therapeutics was $10.47 million, down 14.0% year-over-year; for FY2025, it was $10.35 million, down 28.3% from FY2024.
- In prior years, C4 Therapeutics' Non Operating Income was $14.43 million in FY2024 (+84.6%), $7.82 million in FY2023 (+475.3%), $1.36 million in FY2022 and -$1.76 million in FY2021.
- The Q2 2026 figure stands as the highest quarterly Non Operating Income since Q1 2025.
- On a year-over-year basis, Non Operating Income increased in three of the last eight quarters, with growth averaging 0.8%.
- The strongest year-over-year quarter for Non Operating Income in the past five years was Q3 2023, with growth of 234.7%; the weakest was Q3 2025, with a decline of 37.2%.
- According to Business Quant data, Non Operating Income for the three prior quarters was $2.66 million (Q1 2026), $2.78 million (Q4 2025) and $2.25 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 269.00 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | - |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | - |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | -73.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 387.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | - |
| 10 | C4 Therapeutics | 414.31 Mn | -515.45 Mn | - | 2.79 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.79 Mn |
| Mar 31, 2026 | 2.66 Mn |
| Dec 31, 2025 | 2.78 Mn |
| Sep 30, 2025 | 2.25 Mn |
| Jun 30, 2025 | 2.48 Mn |
| Mar 31, 2025 | 2.84 Mn |
| Dec 31, 2024 | 3.27 Mn |
| Sep 30, 2024 | 3.58 Mn |
| Jun 30, 2024 | 3.73 Mn |
| Mar 31, 2024 | 3.86 Mn |
| Dec 31, 2023 | 2.95 Mn |
| Sep 30, 2023 | 1.77 Mn |
| Jun 30, 2023 | 1.65 Mn |
| Mar 31, 2023 | 1.45 Mn |
| Dec 31, 2022 | 1.11 Mn |
| Sep 30, 2022 | 530,000.00 |
| Jun 30, 2022 | -28,000.00 |
| Mar 31, 2022 | -251,000.00 |
| Dec 31, 2021 | -403,000.00 |
| Sep 30, 2021 | -429,000.00 |
C4 Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=CCCC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "CCCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=CCCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();